Study of the Effectiveness and Safety of Darunavir/Cobicistat (DRV/c) Containing Regimens in Routine Clinical Practice

CompletedOBSERVATIONAL
Enrollment

762

Participants

Timeline

Start Date

December 23, 2016

Primary Completion Date

May 9, 2017

Study Completion Date

May 9, 2017

Conditions
HIV Infections
Trial Locations (20)

Unknown

Hospital Costa del Sol, Málaga

Hospital Clinic i Provincial, Barcelona

Hospital de la Santa Creu i Sant Pau, Barcelona

Hospital del Mar, Barcelona

Hospital del Vall d'Hebron, Barcelona

Hospital Germans Trias i Pujol, Barcelona

Hospital de Guadalajara, Guadalajara

Hospital Infanta Leonor, Madrid

Hospital La Paz, Madrid

Hospital La Princesa, Madrid

Hospital Príncipe de Asturias, Madrid

Hospital Puerta de Hierro, Madrid

Hospital Ramón y Cajal, Madrid

Hospital Virgen de la Victoria, Málaga

Hospital de Son Llatzer, Palma de Mallorca

Hospital de Valme, Seville

Complejo Hospitalario de Toledo, Toledo

Hospital Clínico de Valencia, Valencia

Hospital La Fe, Valencia

Complejo Hospitalaria Alvaron Cunqueiro, Vigo

All Listed Sponsors
collaborator

Janssen-Cilag, S.A.

INDUSTRY

lead

Fundacion SEIMC-GESIDA

OTHER

NCT03042390 - Study of the Effectiveness and Safety of Darunavir/Cobicistat (DRV/c) Containing Regimens in Routine Clinical Practice | Biotech Hunter | Biotech Hunter